Corcept Therapeutics (CORT) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$830.8M

Revenue (quarter)

$256.1M

Revenue growth (year over year)

+31.74%

Gross profit (trailing twelve months)

$816.7M

Gross margin

98.30%

Net income (trailing twelve months)

$55.2M

Net income (quarter)

$43.0M

Net income growth (year over year)

+22.30%

Net margin

6.64%

Return on equity

8.09%

EPS (trailing twelve months)

$0.53

Book value per share

$6.54

P/E (trailing twelve months)

234.64

Price to book

18.04

Debt to assets

20.58%

Payout ratio

—

Dividend yield

—

Company profile

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

• Is Corcept Therapeutics (CORT) profitable?

  Yes. Corcept Therapeutics earned $55.2M in net income over the trailing twelve months, a net margin of 6.64%.

• How much revenue does Corcept Therapeutics (CORT) make?

  Corcept Therapeutics generated $830.8M in revenue over the trailing twelve months, up 31.74% year over year.

• What is CORT's P/E ratio?

  Corcept Therapeutics trades at 234.6 times trailing twelve-month earnings, on an EPS of $0.53.

• How do I buy stock in Corcept Therapeutics (CORT)?

  CORT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.